Latest Breaking News On - Jakafi incyte - Page 3 : comparemela.com

FDA approves Ojjaara for myelofibrosis with anemia

FDA approves Ojjaara for myelofibrosis with anemia
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United-states
Rubena-mesa
Momelotinib-ojjaara
Jakafi-incyte
Atrium-health-levine-cancer-institute
Hemonc-today-editorial-board-member

Axatilimab induces 'robust responses' in chronic GVHD

Axatilimab induces 'robust responses' in chronic GVHD
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Bymark-leiser
Kadmon-sanofi
Carriel-kitko
Jakafi-incyte
Incyte-syndax-pharmaceuticals
Syndax-pharmaceuticals
Vanderbilt-ingram-cancer-center
Syndax-pharmaceuticals-issued

FDA grants fast track designation to myelofibrosis, nasopharyngeal cancer therapies

FDA grants fast track designation to myelofibrosis, nasopharyngeal cancer therapies
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Mindy-valcarcel
Jakafi-incyte
Bymatthew-shinkle
Reshma-rangwala
Karyopharm-therapeutics

Incyte to discontinue phase 3 study of parsaclisib plus ruxolitinib for myelofibrosis

A randomized phase 3 study of parsaclisib plus ruxolitinib for adults with myelofibrosis appeared unlikely to meet its primary endpoint and will be discontinued, according to the agents’ manufacturer.The double-blind LIMBER-304 trial evaluated the safety and efficacy of parsaclisib (Incyte), a novel oral inhibitor of the phosphatidylinositol 3-kinase (PI3K) delta, in combination with the

Mindy-valcarcel
Jakafi-incyte